7575 Stock Overview
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 6/6 |
Japan Lifeline Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,141.00 |
| 52 Week High | JP¥1,357.00 |
| 52 Week Low | JP¥908.00 |
| Beta | 0.15 |
| 1 Month Change | -9.73% |
| 3 Month Change | -11.89% |
| 1 Year Change | 25.11% |
| 3 Year Change | -25.72% |
| 5 Year Change | -34.87% |
| Change since IPO | 729.82% |
Recent News & Updates
Shareholder Returns
| 7575 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | -3.4% | 1.4% | -2.6% |
| 1Y | 25.1% | 10.7% | 28.4% |
Return vs Industry: 7575 exceeded the JP Medical Equipment industry which returned 10.7% over the past year.
Return vs Market: 7575 underperformed the JP Market which returned 28.4% over the past year.
Price Volatility
| 7575 volatility | |
|---|---|
| 7575 Average Weekly Movement | 2.8% |
| Medical Equipment Industry Average Movement | 3.9% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in JP Market | 8.2% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 7575 has not had significant price volatility in the past 3 months.
Volatility Over Time: 7575's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 1,166 | Keisuke Suzuki | www.japanlifeline.com |
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company’s cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts, as well as embolic coil deploying systems; and coronary and peripheral intervention products include PTCA and PTA guide wires, and PTCA balloon catheters.
Japan Lifeline Co., Ltd. Fundamentals Summary
| 7575 fundamental statistics | |
|---|---|
| Market cap | JP¥86.62b |
| Earnings (TTM) | JP¥8.49b |
| Revenue (TTM) | JP¥51.55b |
10.1x
P/E Ratio1.7x
P/S RatioIs 7575 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7575 income statement (TTM) | |
|---|---|
| Revenue | JP¥51.55b |
| Cost of Revenue | JP¥20.49b |
| Gross Profit | JP¥31.06b |
| Other Expenses | JP¥22.57b |
| Earnings | JP¥8.49b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 01, 2024
| Earnings per share (EPS) | 113.35 |
| Gross Margin | 60.25% |
| Net Profit Margin | 16.47% |
| Debt/Equity Ratio | 7.3% |
How did 7575 perform over the long term?
See historical performance and comparison